ORKA

Oruka Therapeutics, Inc.

Healthcare · Biotechnology

$176.30 sample

+2.33 (+1.34%) 1D

Market cap

$1.04T

Price as of

2026-10-03

Latest filing

8-K

Alerts

8

Price$176.30 +29.16% 3M daily closessample

176.30135.51

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 25INSInsider buy: Chief Financial Officer
Sep 21INSInsider sell: General Counsel
Sep 14INSInsider sell: EVP, Operations
Sep 04INSInsider buy: Chief Financial Officer
Aug 31INSInsider buy: Chief Financial Officer
Aug 24INSInsider buy: Chief Executive Officer
Aug 17INSInsider sell: 10% owner
Aug 10INSInsider sell: Director

Sign up to see the real ORKA record →

Company facts

SEC EDGAR registration

Name: Oruka Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -47sample, -100 to +100
Reporting currency: USD

Who is positioning in ORKA

sample

Insiders: 23 insider transactions over 90 days, net selling, $788.4M
Congress: 4 members traded over 90 days
Institutions · 13F: 5 funds hold $13.9B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$24.1B +14.5% y/y

Q4 2024Q3 2026

Inventory$13.9B +11.0% y/y

Q4 2024Q3 2026

Accounts receivable$10.7B +12.8% y/y

Q4 2024Q3 2026

Total debt$29.6B +19.2% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $111.0B +0.9% 3M
Sample peer B: $395.4B -6.5% 3M
Sample peer C: $378.1B +10.4% 3M
Sample peer D: $868.3B +4.0% 3M
Sample peer E: $222.6B +8.5% 3M